Hepatitis B virus‐related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non‐viral risk factors-Reference-Cited by-同舟云学术

Hepatitis B virus‐related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non‐viral risk factors

Published:2020-08-03 Issue:10 Volume:40 Page:2316-2325
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Li Wanying¹,Deng Rui¹,Liu Shi¹,Wang Kaifeng¹,Sun Jian¹^ORCID

Affiliation:

1. State Key Laboratory of Organ Failure Research Guangdong Provincial Key Laboratory of Viral Hepatitis Research Department of Infectious Diseases Nanfang HospitalSouthern Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14607

Reference98 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Hepatocellular Carcinoma

3. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

5. Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer;World Journal of Clinical Oncology;2024-04-24

2. Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multicenter Retrospective Cohort Study;Journal of Clinical and Translational Hepatology;2024-03-27

3. Targeting the PI3K/pAKT/mTOR/NF‐κB/FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk;Environmental Toxicology;2024-03-20

4. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma;BMC Cancer;2024-03-04

5. Characterization of m6A RNA methylation mediated immune heterogeneity and functional validation in hepatocellular carcinoma;Environmental Toxicology;2024-02-26